PAINCEPTOR
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| painceptor.com |  |
The "PAINCEPTOR" trademark, serial number 78731402 , was filed on 12th of October 2005 with a mark drawing code of 3000 and its transaction date is 78731402. The attorney assigned is Terrence J. McAllister, attorney docket number 2144.061UST1. Since 30th of June 2010, the document can be found in the M70 law office in the publication and issue section. The date when we last checked the status of this trademark was 12/30/2009.
Other trademarks by this attorney include , LOST ANGELES , EYLIA , ZYVIZA . The corresponded responsible for this trademark is TERRENCE J MCALLISTER, located at OHLANDT, GREELEY, RUGGIERO & PERLE LLP, ONE LANDMARK SQ 10TH FL, STAMFORD, CT 06901-2682.The state or country where the trademark was organized is by Painceptor Pharma Corporation. The legal entity type behing it is a Corporation, located at 7150, Albert-einstein, St-laurent , Quebec, zip H4S 2C1.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 10/18/2005 |
| Primary Code | 005 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 10/18/2005 |
| Primary Code | 042 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| GS0051 | Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Schizophrenia, learning disorders, Bipolar Disorder, Depression, Alzheimer's Disease, Epilepsy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Stroke, Addiction, Cerebral Ischemia, Neuropathy, Retinal Pigment Degeneneration, Glaucoma, Cardiac Arrhythmia, Shingles, Huntington's Chorea, Parkinson's Disease and anxiety disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases of the musculoskeletal and connective tissue system, Respiratory system, Circulatory system, Gastrointestinal system, Genitourinary system and Nervous system; Pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal and connective tissue system, namely, Arthritis, Psoriasis, Myocitis, Dermatitis, bone cancer and eczema; Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system, namely, Asthma, Bronchitis, Sinusitis, Pharyngitis, Laryngitis, Tracheitis, rhinitis, Cystic fibrosis, Respiratory Infection, Acute respiratory Distress syndrome and emphysema; Pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system, namely, Vasculitis, Haematuria syndrome, Artherosclerosis, Arteritis, Phlebitis, Carditis, Coronary Heart Disease, Ischemic Heart Disease, Angina and Acute Myocardial Infarction; Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, namely, Irritable Bowel Syndrome, Ulcerative colitis, Crohn's Disease, Diverticulitis, Viral and Bacterial Infection, Peptic ulcer, Chronic hepatitis, Gingivitis, Periodentitis, Stomatitis, Gastritis, Gastrointestinal reflux disease and GI cancers; Pharmaceutical preparations for the treatment of the genitourinary diseases and disorders, namely, Cystitis, Polycystic kidney disease, Nephritic syndrome, Urinary Tract infection, Kidney Stones, Cystinosis, Prostatitis, Salpingitis, Endometriosis and GU cancers; Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, namely, Neuralgia, Neuropathy, Chronic cephalic pain, headache, migraine, psychogenic pain and spinal cord injury |
| GS0421 | Pharmaceutical research and development, product evaluation and drug development |
| FOREGIN REGISTRATION | |
| Foreign Filing Date | 09/28/2005 |
|---|---|
| Foreign Application Number | 1273815 |
| Country | CA |
DESIGN SETUP
Atomic models; Molecular models . Circles touching or intersecting . Circles, three or more concentric; Concentric circles, three or more; Three or more concentric circles . Circles that are totally or partially shaded. .| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 10/31/2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 10/31/2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 06/30/2010 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 12/30/2009 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 12/17/2009 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 06/17/2009 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 06/15/2009 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 12/12/2008 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 10/17/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 12/12/2008 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 12/12/2008 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 11/13/2008 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 11/13/2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 11/10/2008 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | I - Incoming Correspondence | ERSI | |
| 06/17/2008 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS2 | |
| 06/17/2008 | INQUIRY TO SUSPENSION E-MAILED | S | GNSI - INQUIRY TO SUSPENSION E-MAILED | |
| 06/17/2008 | SUSPENSION INQUIRY WRITTEN | R - Renewal | CNSI - SUSPENSION INQUIRY - COMPLETED | |
| 05/28/2008 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 11/26/2007 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 11/26/2007 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 11/26/2007 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 10/31/2007 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 10/31/2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 06/10/2007 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS2 | |
| 06/10/2007 | INQUIRY TO SUSPENSION E-MAILED | S | GNSI - INQUIRY TO SUSPENSION E-MAILED | |
| 06/10/2007 | SUSPENSION INQUIRY WRITTEN | R - Renewal | CNSI - SUSPENSION INQUIRY - COMPLETED | |
| 05/26/2007 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 05/26/2007 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 11/21/2006 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 11/21/2006 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 10/18/2006 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 10/17/2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 04/17/2006 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 04/17/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 04/17/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 10/18/2005 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.